PDB94 - INITIAL ANTIDIABETIC PHARMACOTHERAPY PRESCRIBED TO PATIENTS WITH NEWLY DIAGNOSED TYPE-2 DIABETES IN A COMMERCIAL HEALTH PLAN IN THE UNITED STATED
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.799
https://www.valueinhealthjournal.com/article/S1098-3015(18)34099-3/fulltext
Title :
PDB94 - INITIAL ANTIDIABETIC PHARMACOTHERAPY PRESCRIBED TO PATIENTS WITH NEWLY DIAGNOSED TYPE-2 DIABETES IN A COMMERCIAL HEALTH PLAN IN THE UNITED STATED
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)34099-3&doi=10.1016/j.jval.2018.09.799
First page :
Section Title :
Open access? :
No
Section Order :
198